[
  {
    "ts": null,
    "headline": "There's uncertainty ahead for the health insurance industry in 2025",
    "summary": "Health insurers faced a tough year, with some faring worse than others. How the upcoming year, and the Trump 2.0 presidency, will impact the stocks remains unclear.",
    "url": "https://finnhub.io/api/news?id=d5df193b386fc0e40566f28632280d6757761fe8377f874146b82f13674ebdf4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735066828,
      "headline": "There's uncertainty ahead for the health insurance industry in 2025",
      "id": 132135204,
      "image": "https://s.yimg.com/ny/api/res/1.2/egVjLw5nZ4jop7.qlEGwlw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03OTg-/https://s.yimg.com/os/creatr-uploaded-images/2024-07/337143e0-438f-11ef-b7f5-718fba3d0e44",
      "related": "ELV",
      "source": "Yahoo",
      "summary": "Health insurers faced a tough year, with some faring worse than others. How the upcoming year, and the Trump 2.0 presidency, will impact the stocks remains unclear.",
      "url": "https://finnhub.io/api/news?id=d5df193b386fc0e40566f28632280d6757761fe8377f874146b82f13674ebdf4"
    }
  },
  {
    "ts": null,
    "headline": "3 biggest catalysts expected for healthcare in 2025",
    "summary": "After an eventful year in the pharmaceutical and biotech industries, what lies ahead for the health landscape in 2025? Yahoo Finance senior health reporter Anjalee Khemlani outlines the three biggest catalysts for change and innovation for healthcare in the new year, including GLP-1 weight-loss drugs and proposed regulations on pharmacy benefit managers (PBMs) from the second Trump administration. To watch more expert insights and analysis on the latest market action, check out more Catalysts here. This post was written by Luke Carberry Mogan.",
    "url": "https://finnhub.io/api/news?id=d257b317d5d05997105840bc14ccb6a93eae24c968c53d9f1a66458a6df399af",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735060800,
      "headline": "3 biggest catalysts expected for healthcare in 2025",
      "id": 132133934,
      "image": "https://s.yimg.com/ny/api/res/1.2/beEG94ULzRzpQ6PW9JqZAQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzY-/https://s.yimg.com/os/creatr-uploaded-images/2024-12/664ed980-c215-11ef-af3f-16c0199a30a2",
      "related": "ELV",
      "source": "Yahoo",
      "summary": "After an eventful year in the pharmaceutical and biotech industries, what lies ahead for the health landscape in 2025? Yahoo Finance senior health reporter Anjalee Khemlani outlines the three biggest catalysts for change and innovation for healthcare in the new year, including GLP-1 weight-loss drugs and proposed regulations on pharmacy benefit managers (PBMs) from the second Trump administration. To watch more expert insights and analysis on the latest market action, check out more Catalysts here. This post was written by Luke Carberry Mogan.",
      "url": "https://finnhub.io/api/news?id=d257b317d5d05997105840bc14ccb6a93eae24c968c53d9f1a66458a6df399af"
    }
  },
  {
    "ts": null,
    "headline": "Elevance Health Inc. stock rises Tuesday, still underperforms market",
    "summary": "Elevance Health Inc. stock rises Tuesday, still underperforms market",
    "url": "https://finnhub.io/api/news?id=e05cc60cd0c5b7be896cbd4aebca6ba88224806a39487a424b81c0f37d9402c7",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735058640,
      "headline": "Elevance Health Inc. stock rises Tuesday, still underperforms market",
      "id": 132149588,
      "image": "",
      "related": "ELV",
      "source": "MarketWatch",
      "summary": "Elevance Health Inc. stock rises Tuesday, still underperforms market",
      "url": "https://finnhub.io/api/news?id=e05cc60cd0c5b7be896cbd4aebca6ba88224806a39487a424b81c0f37d9402c7"
    }
  }
]